{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:50:14Z","timestamp":1792900214127,"version":"4.5.0"},"reference-count":101,"publisher":"American Chemical Society (ACS)","issue":"11","license":[{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-001"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-009"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"}],"funder":[{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The COVID-19 pandemic is caused by the coronavirus SARS-CoV-2 (SC2). A variety of anti-SC2 vaccines have been approved for human applications, including those using messenger RNA (mRNA), adenoviruses expressing SC2 spike (S) protein, and inactivated virus. The protective periods of immunization afforded by these intramuscularly administered vaccines are currently unknown. An alternative self-administrable vaccine capable of mounting long-lasting immunity via sterilizing neutralizing antibodies would be hugely advantageous in tackling emerging mutant SC2 variants. This could also diminish the possibility of vaccinated individuals acting as passive carriers of COVID-19. Here, we investigate the potential of an intranasal (IN)-delivered DNA vaccine encoding the S protein of SC2 in BALB\/c and C57BL\/6J immunocompetent mouse models. The immune response to IN delivery of this SC2-spike DNA vaccine transported on a modified gold-chitosan nanocarrier shows a strong and consistent surge in antibodies (IgG, IgA, and IgM) and effective neutralization of pseudoviruses expressing S proteins of different SC2 variants (Wuhan, beta, and D614G). Immunophenotyping and histological analyses reveal chronological events involved in the recognition of SC2 S antigen by resident dendritic cells and alveolar macrophages, which prime the draining lymph nodes and spleen for peak SC2-specific cellular and humoral immune responses. The attainable high levels of anti-SC2 IgA in lung mucosa and tissue-resident memory T cells can efficiently inhibit SC2 and its variants at the site of entry and also provide long-lasting immunity.<\/jats:p>","DOI":"10.1021\/acsnano.1c05002","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T13:57:49Z","timestamp":1635343069000},"page":"17582-17601","source":"Crossref","is-referenced-by-count":96,"title":["Gold-Nanostar-Chitosan-Mediated\nDelivery of SARS-CoV\u20112\nDNA Vaccine for Respiratory Mucosal Immunization: Development and\nProof-of-Principle"],"prefix":"10.1021","volume":"15","author":[{"given":"Uday S.","family":"Kumar","sequence":"first","affiliation":[{"name":"Stanford University School of Medicine , , , ,","place":["Stanford, California, United States, 94305"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayhaneh","family":"Afjei","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine , , , ,","place":["Stanford, California, United States, 94305"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4976-9107","authenticated-orcid":true,"given":"Katherine","family":"Ferrara","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine , , , ,","place":["Stanford, California, United States, 94305"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9694-1408","authenticated-orcid":true,"given":"Tarik F.","family":"Massoud","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine , , , ,","place":["Stanford, California, United States, 94305"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7155-4738","authenticated-orcid":true,"given":"Ramasamy","family":"Paulmurugan","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine , , , ,","place":["Stanford, California, United States, 94305"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2021,10,27]]},"reference":[{"key":"2026081810144424500_cit1","unstructured":"WHO Coronavirus (COVID-19)\nDashboard. https:\/\/covid19.who.int (accessed\n2021-03-13)."},{"issue":"5","key":"2026081810144424500_cit2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jiph.2020.03.019","article-title":"Coronavirus\nDisease 2019 (COVID-19): A Literature Review","volume":"13","author":"Harapan","year":"2020","journal-title":"J. Infect Public Health"},{"issue":"7830","key":"2026081810144424500_cit3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2\nVaccines in Development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"2026081810144424500_cit4","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2183","article-title":"Severe Acute\nRespiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine\nCandidates: State of the Art and Future Prospects","volume":"31","author":"Arashkia","year":"2021","journal-title":"Rev. Med. Virol."},{"issue":"2","key":"2026081810144424500_cit5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/vaccines9020147","article-title":"SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond","volume":"9","author":"Bettini","year":"2021","journal-title":"Vaccines (Basel, Switz.)"},{"key":"2026081810144424500_cit6","unstructured":"WHO COVID-19 Vaccine Tracker and Landscape. https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines (accessed 2021-03-13)."},{"issue":"11","key":"2026081810144424500_cit7","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.4161\/rna.22269","article-title":"Developing mRNA-Vaccine\nTechnologies","volume":"9","author":"Schlake","year":"2012","journal-title":"RNA Biol."},{"issue":"1","key":"2026081810144424500_cit8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A Single-Dose\nIntranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts\nagainst SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"issue":"3","key":"2026081810144424500_cit9","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1542\/peds.100.3.400","article-title":"Needle Length and Injection\nTechnique\nfor Efficient Intramuscular Vaccine Delivery in Infants and Children\nEvaluated through an Ultrasonographic Determination of Subcutaneous\nand Muscle Layer Thickness","volume":"100","author":"Groswasser","year":"1997","journal-title":"Pediatrics"},{"issue":"21","key":"2026081810144424500_cit10","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1001\/jama.277.21.1709","article-title":"Determination\nof Deltoid Fat Pad Thickness. Implications for Needle Length in Adult\nImmunization","volume":"277","author":"Poland","year":"1997","journal-title":"JAMA, J. Am. Med. Assoc."},{"issue":"5","key":"2026081810144424500_cit11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0264-410X(89)90157-6","article-title":"Effect of Anatomic Injection Site,\nAge and Smoking on the Immune Response to Hepatitis B Vaccination","volume":"7","author":"Shaw","year":"1989","journal-title":"Vaccine"},{"issue":"7271","key":"2026081810144424500_cit12","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1136\/bmj.321.7271.1237","article-title":"The Importance\nof Injecting Vaccines into Muscle. Different Patients Need Different\nNeedle Sizes","volume":"321","author":"Zuckerman","year":"2000","journal-title":"BMJ."},{"key":"2026081810144424500_cit13","doi-asserted-by":"publisher","first-page":"n1605","DOI":"10.1136\/bmj.n1605","article-title":"How Long Does\nCovid-19 Immunity Last?","volume":"373","author":"Baraniuk","year":"2021","journal-title":"BMJ."},{"key":"2026081810144424500_cit14","unstructured":"CDC Interim Clinical Considerations for Use of\nCOVID-19 Vaccines\nCurrently Authorized in the United States. https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/covid-19-vaccines-us.html (accessed 2021-03-13)."},{"key":"2026081810144424500_cit15","doi-asserted-by":"publisher","first-page":"571481","DOI":"10.3389\/fimmu.2020.571481","article-title":"Will SARS-CoV-2 Infection Elicit\nLong-Lasting Protective or Sterilising Immunity? Implications for\nVaccine Strategies (2020)","volume":"11","author":"Kim","year":"2020","journal-title":"Front. Immunol."},{"key":"2026081810144424500_cit16","doi-asserted-by":"publisher","first-page":"100098","DOI":"10.1016\/j.lanepe.2021.100098","article-title":"Prevalence of Antibody\nPositivity to SARS-CoV-2 Following the First Peak of Infection in\nEngland: Serial Cross-Sectional Studies of 365,000 Adults","volume":"4","author":"Ward","year":"2021","journal-title":"Lancet Reg Health Eur."},{"issue":"8","key":"2026081810144424500_cit17","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202001812","article-title":"Next-Generation\nVaccines: Nanoparticle-Mediated DNA and mRNA Delivery","volume":"10","author":"Ho","year":"2021","journal-title":"Adv. Healthcare Mater."},{"key":"2026081810144424500_cit18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2021.07.021","article-title":"Intranasal\nVaccines for SARS-CoV-2: From Challenges to Potential in COVID-19\nManagement","author":"Chavda","year":"2021","journal-title":"Drug Discovery Today"},{"key":"2026081810144424500_cit19","doi-asserted-by":"crossref","unstructured":"King, R. G.; Silva-Sanchez, A.; Peel, J.\nN.; Botta, D.; Meza-Perez, S.; Allie, R.; Schultz, M. D.; Liu, M.; Bradley, J. E.; Qiu, S.; Yang, G.; Zhou, F.; Zumaquero, E.; Simpler, T. S.; Mousseau, B.; Killian, J. T.; Dean, B.; Shang, Q.; Tipper, J. L.; Risley, C.; \n               , et al.\n          Single-Dose Intranasal Administration of AdCOVID Elicits Systemic\nand Mucosal Immunity Against SARS-CoV-2 in Mice. bioRxiv, October 11, 2020, 331348, ver. 1. https:\/\/www.biorxiv.org\/content\/10.1101\/2020.10.10.331348v1 (accessed 2021-03-13).","DOI":"10.1101\/2020.10.10.331348"},{"issue":"11","key":"2026081810144424500_cit20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.4155\/tde-2019-0010","article-title":"Nanogels as Drug-Delivery Systems:\na Comprehensive Overview","volume":"10","author":"Suhail","year":"2019","journal-title":"Ther. Delivery"},{"key":"2026081810144424500_cit21","doi-asserted-by":"crossref","unstructured":"An, X.; Martinez-Paniagua, M.; Rezvan, A.; Fathi, M.; Singh, S.; Biswas, S.; Pourpak, M.; Yee, C.; Liu, X.; Varadarajan, N.\n          Single-Dose Intranasal Vaccination Elicits Systemic\nand Mucosal Immunity Against SARS-CoV-2. bioRxiv, July 23, 2020, 212357, ver. 1.https:\/\/www.biorxiv.org\/content\/10.1101\/2020.07.23.212357v1 (accessed 2020-12-16).","DOI":"10.1101\/2020.07.23.212357"},{"issue":"1","key":"2026081810144424500_cit22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ni.3056","article-title":"Antiviral B Cell\nand T Cell Immunity in the Lungs","volume":"16","author":"Chiu","year":"2015","journal-title":"Nat. Immunol."},{"issue":"6","key":"2026081810144424500_cit23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The\nTrinity of COVID-19: Immunity, Inflammation and Intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"2026081810144424500_cit24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1183\/09031936.93.06010120","article-title":"Regulation\nof Antigen-Presenting Cell function(s) in Lung and Airway Tissues","volume":"6","author":"Holt","year":"1993","journal-title":"Eur. Respir. J."},{"issue":"4","key":"2026081810144424500_cit25","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1164\/ajrccm.162.supplement_3.15tac2","article-title":"Antigen\nPresentation in the Lung","volume":"162","author":"Holt","year":"2000","journal-title":"Am. J. Respir. Crit.\nCare Med."},{"issue":"3","key":"2026081810144424500_cit26","first-page":"27","article-title":"Transcription\nand Chromatin Subunit Structure","author":"Axel","year":"1976","journal-title":"Adv. Pathobiol"},{"issue":"1","key":"2026081810144424500_cit27","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1128\/IAI.72.1.238-246.2004","article-title":"Single Intranasal Mucosal\nMycobacterium Bovis BCG Vaccination Confers Improved Protection Compared\nto Subcutaneous Vaccination Against Pulmonary Tuberculosis","volume":"72","author":"Chen","year":"2004","journal-title":"Infect. Immun."},{"issue":"4\u20135","key":"2026081810144424500_cit28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3109\/08820131003680369","article-title":"Function of\nMucosa-Associated Lymphoid Tissue in Antibody Formation","volume":"39","author":"Brandtzaeg","year":"2010","journal-title":"Immunol. Invest."},{"issue":"2","key":"2026081810144424500_cit29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal\nVaccines: The Promise and the Challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat.\nRev. Immunol."},{"issue":"3","key":"2026081810144424500_cit30","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3390\/pharmaceutics6030378","article-title":"Intranasal DNA Vaccine for Protection\nagainst Respiratory Infectious Diseases: The Delivery Perspectives","volume":"6","author":"Xu","year":"2014","journal-title":"Pharmaceutics"},{"issue":"1\u20133","key":"2026081810144424500_cit31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0169-409X(01)00162-4","article-title":"Nasal Vaccines","volume":"51","author":"Davis","year":"2001","journal-title":"Adv. Drug Delivery\nRev."},{"key":"2026081810144424500_cit32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jneuroim.2017.04.008","article-title":"Virus Entry\nand Replication in the Brain Precedes Blood-Brain Barrier Disruption\nDuring Intranasal Alphavirus Infection","volume":"308","author":"Cain","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"14","key":"2026081810144424500_cit33","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1016\/j.vaccine.2010.01.011","article-title":"Chitosan-Based Nanoparticles for\nImproving Immunization against Hepatitis B Infection","volume":"28","author":"Prego","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"2026081810144424500_cit34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/pharmaceutics9040053","article-title":"An Overview of Chitosan\nNanoparticles and Its Application in Non-Parenteral Drug Delivery","volume":"9","author":"Mohammed","year":"2017","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"2026081810144424500_cit35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.10.033","article-title":"Chitosan Formulations Improve the\nImmunogenicity of\na GnRH-I Peptide-Based Vaccine","volume":"369","author":"Saenz","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"2","key":"2026081810144424500_cit36","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11095-012-0891-5","article-title":"Nanocarriers\nTargeting Dendritic Cells for Pulmonary Vaccine Delivery","volume":"30","author":"Kunda","year":"2013","journal-title":"Pharm. Res."},{"issue":"3","key":"2026081810144424500_cit37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/21645515.2017.1377376","article-title":"Immune\nResponses\nAfter Live Attenuated Influenza Vaccination","volume":"14","author":"Mohn","year":"2018","journal-title":"Hum. Vaccines Immunother."},{"issue":"2","key":"2026081810144424500_cit38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2217\/nnm.13.58","article-title":"Gold Nanoparticle-M2e\nConjugate Coformulated\nwith CpG Induces Protective Immunity against Influenza A Virus","volume":"9","author":"Tao","year":"2014","journal-title":"Nanomedicine (London, U. K.)"},{"key":"2026081810144424500_cit39","doi-asserted-by":"publisher","first-page":"119342","DOI":"10.1016\/j.biomaterials.2019.119342","article-title":"Intranasal\nDelivery of Targeted Polyfunctional Gold-Iron Oxide Nanoparticles\nLoaded with Therapeutic MicroRNAs for Combined Theranostic Multimodality\nImaging and Presensitization of Glioblastoma to Temozolomide","volume":"218","author":"Sukumar","year":"2019","journal-title":"Biomaterials"},{"issue":"4","key":"2026081810144424500_cit40","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.molimm.2008.08.277","article-title":"Peptides Conjugated\nto Gold Nanoparticles Induce Macrophage Activation","volume":"46","author":"Bastus","year":"2009","journal-title":"Mol. Immunol."},{"issue":"16","key":"2026081810144424500_cit41","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1021\/acs.jpclett.1c00663","article-title":"Intermolecular Interaction\nAnalyses on SARS-CoV-2 Spike Protein Receptor Binding Domain and Human\nAngiotensin-Converting Enzyme 2 Receptor-Blocking Antibody\/Peptide\nUsing Fragment Molecular Orbital Calculation","volume":"12","author":"Watanabe","year":"2021","journal-title":"J. Phys. Chem. Lett."},{"issue":"3","key":"2026081810144424500_cit42","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1586\/14760584.2016.1124762","article-title":"Molecular\nMechanisms for Enhanced DNA Vaccine Immunogenicity","volume":"15","author":"Li","year":"2016","journal-title":"Expert Rev. Vaccines"},{"issue":"3","key":"2026081810144424500_cit43","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0168-3659(00)00330-8","article-title":"A Novel\nBioadhesive Intranasal Delivery\nSystem for Inactivated Influenza Vaccines","volume":"70","author":"Singh","year":"2001","journal-title":"J.\nControlled Release"},{"key":"2026081810144424500_cit44","doi-asserted-by":"publisher","first-page":"32973","DOI":"10.1038\/srep32973","article-title":"Sterilizing Immunity\nto Influenza\nVirus Infection Requires Local Antigen-Specific T Cell Response in\nthe Lungs","volume":"6","author":"Dutta","year":"2016","journal-title":"Sci. Rep."},{"issue":"45","key":"2026081810144424500_cit45","doi-asserted-by":"publisher","first-page":"abc9999","DOI":"10.1126\/sciadv.abc9999","article-title":"Cross-Reactive Neutralization\nof SARS-CoV-2 by Serum Antibodies from Recovered SARS Patients and\nImmunized Animals","volume":"6","author":"Zhu","year":"2020","journal-title":"Sci. Adv."},{"issue":"6531","key":"2026081810144424500_cit46","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.abf4830","article-title":"Broad and Potent Activity against SARS-like Viruses\nby an Engineered Human Monoclonal Antibody","volume":"371","author":"Rappazzo","year":"2021","journal-title":"Science"},{"key":"2026081810144424500_cit47","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1056\/NEJMoa2108453","article-title":"Pan-Sarbecovirus Neutralizing Antibodies\nin BNT162b2-Immunized SARS-CoV-1 Survivors","volume":"385","author":"Tan","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"2026081810144424500_cit48","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000509716","article-title":"Different Innate Immune\nResponses in BALB\/c and C57BL\/6 Strains Following Corneal Transplantation","volume":"13","author":"Bleul","year":"2021","journal-title":"J. Innate Immun."},{"issue":"3","key":"2026081810144424500_cit49","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/003655202317284165","article-title":"Differential Susceptibility\nof Inbred Mouse Strains to Helicobacter Pylori Infection","volume":"37","author":"Mahler","year":"2002","journal-title":"Scand. J. Gastroenterol."},{"key":"2026081810144424500_cit50","doi-asserted-by":"crossref","unstructured":"Skums, P.; Kirpich, A.; Icer Baykal, P.; Zelikovsky, A.; Chowell, G.\n          Global\nTransmission\nNetwork of SARS-CoV-2: From Outbreak to Pandemic. medRxiv, March 27, 2020, ver. 1. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.03.22.20041145v1 (accessed 2020-06-20).","DOI":"10.1101\/2020.03.22.20041145"},{"issue":"4","key":"2026081810144424500_cit51","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","article-title":"Resistance of SARS-CoV-2\nVariants to Neutralization by Monoclonal\nand Serum-Derived Polyclonal Antibodies","volume":"27","author":"Chen","year":"2021","journal-title":"Nat.\nMed."},{"key":"2026081810144424500_cit52","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1126\/science.abg9175","article-title":"mRNA Vaccination\nBoosts Cross-Variant\nNeutralizing Antibodies Elicited by SARS-CoV-2 Infection","volume":"372","author":"Stamatatos","year":"2021","journal-title":"Science"},{"issue":"21","key":"2026081810144424500_cit53","doi-asserted-by":"publisher","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell Entry Mechanisms\nof SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc.\nNatl. Acad. Sci. U. S. A."},{"key":"2026081810144424500_cit54","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3389\/fimmu.2018.00934","article-title":"Mucosal\nImmunity and Protective Efficacy of Intranasal Inactivated Influenza\nVaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs","volume":"9","author":"Dhakal","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"2026081810144424500_cit55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249499","article-title":"Human IgG and IgA Responses to COVID-19\nmRNA Vaccines","volume":"16","author":"Wisnewski","year":"2021","journal-title":"PLoS One"},{"issue":"577","key":"2026081810144424500_cit56","doi-asserted-by":"publisher","first-page":"abd2223","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA Dominates\nthe Early Neutralizing Antibody Response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"2026081810144424500_cit57","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1038\/s41467-020-18058-8","article-title":"A Cross-Reactive\nHuman IgA Monoclonal Antibody Blocks SARS-CoV-2 Spike-ACE2 Interaction","volume":"11","author":"Ejemel","year":"2020","journal-title":"Nat. Commun."},{"key":"2026081810144424500_cit58","doi-asserted-by":"crossref","unstructured":"Ejemel, M.; Li, Q.; Hou, S.; Schiller, Z. A.; Wallace, A. L.; Amcheslavsky, A.; Yilmaz, N. K.; Toomey, J. R.; Schneider, R.; Close, B. J.; Chen, D. Y.; Conway, H. L.; Mohsan, S.; Cavacini, L. A.; Klempner, M. S.; Schiffer, C. A.; Wang, Y.\n          IgA MAb Blocks SARS-CoV-2 Spike-ACE2\nInteraction\nProviding Mucosal Immunity. bioRxiv, May 5, 2020, ver. 1. https:\/\/www.biorxiv.org\/content\/10.1101\/2020.05.15.096719v1 (accessed 2020-12-09).","DOI":"10.1101\/2020.05.15.096719"},{"key":"2026081810144424500_cit59","doi-asserted-by":"publisher","first-page":"611337","DOI":"10.3389\/fimmu.2020.611337","article-title":"Mucosal Immunity in\nCOVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection","volume":"11","author":"Russell","year":"2020","journal-title":"Front. Immunol."},{"issue":"10","key":"2026081810144424500_cit60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241104","article-title":"Serum-IgG Responses to SARS-CoV-2 After Mild and Severe\nCOVID-19 Infection and Analysis of IgG Non-Responders","volume":"15","author":"Marklund","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"2026081810144424500_cit61","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The Impact\nof Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"2026081810144424500_cit62","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3389\/fimmu.2020.01949","article-title":"Overview of\nImmune Response during SARS-CoV-2 Infection: Lessons from the Past","volume":"11","author":"Shah","year":"2020","journal-title":"Front. Immunol."},{"key":"2026081810144424500_cit63","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.antiviral.2016.11.006","article-title":"T-Cell\nImmunity of SARS-CoV: Implications for Vaccine\nDevelopment against MERS-CoV","volume":"137","author":"Liu","year":"2017","journal-title":"Antiviral Res."},{"issue":"1","key":"2026081810144424500_cit64","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/ni.3052","article-title":"The Development and Function of Lung-Resident\nMacrophages and Dendritic Cells","volume":"16","author":"Kopf","year":"2015","journal-title":"Nat. Immunol."},{"issue":"5","key":"2026081810144424500_cit65","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1513\/pats.200508-090JS","article-title":"Innate\nImmunity in the Lungs","volume":"2","author":"Martin","year":"2005","journal-title":"Proc. Am. Thorac. Soc."},{"key":"2026081810144424500_cit66","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.3389\/fimmu.2020.01722","article-title":"Pulmonary\nInnate Immune Response Determines the Outcome of Inflammation During\nPneumonia and Sepsis-Associated Acute Lung Injury","volume":"11","author":"Kumar","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"2026081810144424500_cit67","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1183\/09031936.01.18040692","article-title":"Lung Dendritic Cells and Host Immunity\nto Infection","volume":"18","author":"Lambrecht","year":"2001","journal-title":"Eur. Respir. J."},{"key":"2026081810144424500_cit68","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-540-71029-5_2","article-title":"Dendritic Cell Migration to Peripheral\nLymph Nodes","volume":"188","author":"Martin-Fontecha","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"2026081810144424500_cit69","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fimmu.2019.00022","article-title":"Nanoparticle-Based Vaccines Against\nRespiratory Viruses","volume":"10","author":"Al-Halifa","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"2026081810144424500_cit70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41565-020-0739-9","article-title":"Advances in Nanomaterial\nVaccine Strategies to Address\nInfectious Diseases Impacting Global Health","volume":"16","author":"Fries","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"2026081810144424500_cit71","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/mi.2012.106","article-title":"Migratory Properties\nof Pulmonary Dendritic Cells Are Determined by Their Developmental\nLineage","volume":"6","author":"Nakano","year":"2013","journal-title":"Mucosal Immunol."},{"key":"2026081810144424500_cit72","doi-asserted-by":"publisher","first-page":"e52739","DOI":"10.3791\/52739","article-title":"Mouse Naive CD4+\nT Cell Isolation and in Vitro Differentiation into\nT Cell Subsets","volume":"98","author":"Flaherty","year":"2015","journal-title":"J. Visualized\nExp."},{"key":"2026081810144424500_cit73","doi-asserted-by":"publisher","first-page":"102885","DOI":"10.1016\/j.ebiom.2020.102885","article-title":"Reappearance of Effector T Cells\nis Associated with Recovery from COVID-19","volume":"57","author":"Odak","year":"2020","journal-title":"EBioMedicine"},{"issue":"9","key":"2026081810144424500_cit74","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nri2379","article-title":"T-Cell Activation\nby Dendritic Cells in the Lymph Node: Lessons from the Movies","volume":"8","author":"Bousso","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"2026081810144424500_cit75","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1172\/JCI9591","article-title":"Dendritic\nCells: At the Clinical Crossroads","volume":"105","author":"Mule","year":"2000","journal-title":"J. Clin.\nInvest."},{"issue":"10","key":"2026081810144424500_cit76","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1002\/eji.200535446","article-title":"Splenic Marginal Zone B Cells in\nHumans: Where Do They Mutate Their Ig Receptor?","volume":"35","author":"Weller","year":"2005","journal-title":"Eur. J. Immunol."},{"issue":"6","key":"2026081810144424500_cit77","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1046\/j.1365-3083.1998.00471.x","article-title":"Dendritic Cells Enhance the Differentiation\nof Naive\nB Cells into Plasma Cells in Vitro","volume":"48","author":"Fayette","year":"1998","journal-title":"Scand. J. Immunol."},{"issue":"3","key":"2026081810144424500_cit78","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4049\/jimmunol.161.3.1313","article-title":"Dendritic\nCells Interact Directly with Naive B Lymphocytes to Transfer Antigen\nand Initiate Class Switching in a Primary T-Dependent Response","volume":"161","author":"Wykes","year":"1998","journal-title":"J. Immunol"},{"issue":"3","key":"2026081810144424500_cit79","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/eji.201444983","article-title":"Antigen Targeting Reveals Splenic CD169+ Macrophages\nas Promoters of Germinal Center B-Cell Responses","volume":"45","author":"Veninga","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"2026081810144424500_cit80","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jdermsci.2015.11.008","article-title":"Efficient Antigen Delivery to the Draining Lymph Nodes\nis a Key Component in the Immunogenic Pathway of the Intradermal Vaccine","volume":"82","author":"Tozuka","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"2026081810144424500_cit81","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.addr.2020.06.019","article-title":"Controlling\nTiming and Location in\nVaccines","volume":"158","author":"Irvine","year":"2020","journal-title":"Adv. Drug Delivery Rev."},{"issue":"10","key":"2026081810144424500_cit82","doi-asserted-by":"publisher","first-page":"12370","DOI":"10.1021\/acsnano.0c06109","article-title":"Engineering Antiviral Vaccines","volume":"14","author":"Zhou","year":"2020","journal-title":"ACS Nano"},{"key":"2026081810144424500_cit83","doi-asserted-by":"publisher","first-page":"109948","DOI":"10.1016\/j.mehy.2020.109948","article-title":"B-Cell\nEngineering: A Promising Approach towards Vaccine Development for\nCOVID-19","volume":"144","author":"Faiq","year":"2020","journal-title":"Med. Hypotheses"},{"key":"2026081810144424500_cit84","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fimmu.2019.00347","article-title":"Lymph Node Subcapsular Sinus Macrophages\nas the Frontline\nof Lymphatic Immune Defense","volume":"10","author":"Louie","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"2026081810144424500_cit85","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41590-019-0427-9","article-title":"B Cell\nSignaling in Context","volume":"20","author":"Kwak","year":"2019","journal-title":"Nat. Immunol."},{"issue":"3","key":"2026081810144424500_cit86","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-2249.2012.04602.x","article-title":"Lymph Node Dissection\ue5f8Understanding\nthe Immunological Function\nof Lymph Nodes","volume":"169","author":"Buettner","year":"2012","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"2026081810144424500_cit87","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1002\/eji.201747248","article-title":"Spreading\nthe Load: Antigen Transfer between Migratory and Lymph Node-Resident\nDendritic Cells Promotes T-Cell Priming","volume":"47","author":"Mueller","year":"2017","journal-title":"Eur.\nJ. Immunol."},{"issue":"10\u201311","key":"2026081810144424500_cit88","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.addr.2011.05.018","article-title":"The Role of the Lymphatic System in Vaccine Trafficking\nand Immune Response","volume":"63","author":"Pal","year":"2011","journal-title":"Adv. Drug Delivery Rev."},{"issue":"9","key":"2026081810144424500_cit89","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1016\/j.celrep.2019.10.086","article-title":"Follicular Dendritic Cells Modulate\nGerminal Center B Cell Diversity through FcgammaRIIB","volume":"29","author":"van\nder Poel","year":"2019","journal-title":"Cell Rep."},{"issue":"7502","key":"2026081810144424500_cit90","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/509573a","article-title":"Immunology:\nTo Affinity and Beyond","volume":"509","author":"Tarlinton","year":"2014","journal-title":"Nature"},{"issue":"1","key":"2026081810144424500_cit91","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.smim.2007.12.001","article-title":"Follicular Dendritic\nCell Networks of Primary Follicles\nand Germinal Centers: Phenotype and Function","volume":"20","author":"Allen","year":"2008","journal-title":"Semin. Immunol."},{"issue":"12","key":"2026081810144424500_cit92","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1084\/jem.20111449","article-title":"Follicular Dendritic\nCells Help Establish Follicle\nIdentity and Promote B Cell Retention in Germinal Centers","volume":"208","author":"Wang","year":"2011","journal-title":"J. Exp. Med."},{"issue":"43","key":"2026081810144424500_cit93","doi-asserted-by":"publisher","first-page":"E6639","DOI":"10.1073\/pnas.1606050113","article-title":"Sustained Antigen Availability during\nGerminal Center\nInitiation Enhances Antibody Responses to Vaccination","volume":"113","author":"Tam","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026081810144424500_cit94","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coi.2019.04.003","article-title":"Antigen Presentation\nby Dendritic Cells for B Cell Activation","volume":"58","author":"Heath","year":"2019","journal-title":"Curr.\nOpin. Immunol."},{"key":"2026081810144424500_cit95","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3389\/fimmu.2016.00225","article-title":"How Follicular Dendritic Cells Shape\nthe B-Cell Antigenome","volume":"7","author":"Kranich","year":"2016","journal-title":"Front. Immunol."},{"key":"2026081810144424500_cit96","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3389\/fimmu.2018.00805","article-title":"Follicular\nDendritic Cells of Lymph\nNodes as Human Immunodeficiency Virus\/Simian Immunodeficiency Virus\nReservoirs and Insights on Cervical Lymph Node","volume":"9","author":"Dave","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"2026081810144424500_cit97","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1084\/jem.192.7.931","article-title":"Germinal\nCenter Initiation, Variable Gene Region Hypermutation, and Mutant\nB Cell Selection without Detectable Immune Complexes on Follicular\nDendritic Cells","volume":"192","author":"Hannum","year":"2000","journal-title":"J. Exp. Med."},{"issue":"7","key":"2026081810144424500_cit98","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/0167-5699(94)90078-7","article-title":"T Cells as Antigen-Presenting Cells","volume":"15","author":"Pichler","year":"1994","journal-title":"Immunol Today"},{"issue":"6","key":"2026081810144424500_cit99","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1089\/vim.2017.0016","article-title":"Persistence\nin Temporary Lung Niches: A Survival Strategy of Lung-Resident Memory\nCD8\u00ad(+) T Cells","volume":"30","author":"Takamura","year":"2017","journal-title":"Viral Immunol."},{"issue":"1","key":"2026081810144424500_cit100","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1515\/bmc-2018-0007","article-title":"Interferon-Gamma\n(IFN-Gamma): Exploring\nIts Implications in Infectious Diseases","volume":"9","author":"Kak","year":"2018","journal-title":"Biomol.\nConcepts"},{"issue":"6","key":"2026081810144424500_cit101","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/vaccines9060641","article-title":"A Murine CD8\u00ad(+)\nT Cell Epitope Identified in the Receptor-Binding Domain of the SARS-CoV-2\nSpike Protein","volume":"9","author":"Yang","year":"2021","journal-title":"Vaccines (Basel, Switz.)"}],"container-title":["ACS Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsnano.1c05002","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/ancac3\/article-pdf\/15\/11\/17582\/15154405\/nn1c05002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/ancac3\/article-pdf\/15\/11\/17582\/15154405\/nn1c05002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:53:37Z","timestamp":1787072017000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/ancac3\/article\/15\/11\/17582\/1437865\/Gold-Nanostar-Chitosan-Mediated-Delivery-of-SARS"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,27]]},"references-count":101,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,10,27]]},"published-print":{"date-parts":[[2021,11,23]]}},"URL":"https:\/\/doi.org\/10.1021\/acsnano.1c05002","relation":{},"ISSN":["1936-0851","1936-086X"],"issn-type":[{"value":"1936-0851","type":"print"},{"value":"1936-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,27]]}}}